A patient with MF experienced hyperprogression upon anti–PD-1 therapy.
tumors
TUMORS, GENERALIZED ERYTHRODERMA
A 52-year-old man who had a 13-year history of MF presented to our clinic with generalized erythroderma and multiple tumors in October, 2018 (